2Toubai T, Tanaka J, Ota S, et al. Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies. Intern Med ,2007,46:3-9.
3Joseph JM,Jain R, Danziger LH. Micafungin : a new echinocandin antifungal. Pharmacotherapy, 2007,27:53-67.
4Nakagawa Y, lchii Y, Saeki Y, et al. micafungin in patients with hematologic malignancies. Infect Chemother,2007 ,13 :39-45.
3Tamura K, Urabo A.Yoshida M, et al. Efficacy and safety of mi- cafun-Gin,an echinocandin antifungal agent.on invasive fungal infections in patients with hematological disorders[J]. Leuk Lym- phoma, 2009,50( 1 ) : 92-100.
4De Wet NT, Bester A J, Viljoen J J, et al. A randomized, double blind, comparative trial of micafungin (FK463) VS.fluconazole for the treatment of oesophageal candidiasis[J]. Aliment Pharma- col Ther, 2005,21 (7) : 899-907.
5Kohno S, Masaoka T, Yamaguchi H,et al. A multicenter, open- label clinical study of mieafungin (FK463)in the treatment eep- seated mycosis in Japan [J]. Scand J Infect Dis,2004,36 (5): 372-379.
